Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation |
| |
Authors: | Mostafa T. Mohammed Songjie Cai Benjamin L. Hanson Hengcheng Zhang Rachel L. Clement Joe Daccache Cecilia B. Cavazzoni Bruce R. Blazar Alessandro Alessandrini Helmut G. Rennke Anil Chandraker Peter T. Sage |
| |
Affiliation: | 1. Clinical Pathology Department, Faculty of Medicine, Minia University, Minia, Egypt;2. Transplantation Research Center, Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;3. Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota;4. Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts;5. Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts |
| |
Abstract: | Following solid organ transplantation, a substantial proportion of chronic allograft loss is attributed to the formation of donor-specific antibodies (DSAs) and antibody-mediated rejection (AbMR). The frequency and phenotype of T follicular helper (Tfh) and T follicular regulatory (Tfr) cells is altered in the setting of kidney transplantation, particularly in patients who develop AbMR. However, the roles of Tfh and Tfr cells in AbMR after solid organ transplantation is unclear. We developed mouse models to inducibly and potently perturb Tfh and Tfr cells to assess the roles of these cells in the development of DSA and AbMR. We found that Tfh cells are required for both de novo DSA responses as well as augmentation of DSA following presensitization. Using orthotopic allogeneic kidney transplantation models, we found that deletion of Tfh cells at the time of transplantation resulted in less severe transplant rejection. Furthermore, using inducible Tfr cell deletion strategies we found that Tfr cells inhibit de novo DSA formation but only have a minor role in controlling kidney transplant rejection. These studies demonstrate that Tfh cells promote, whereas Tfr cells inhibit, DSA to control rejection after kidney transplantation. Therefore, targeting these cells represent a new therapeutic strategy to prevent and treat AbMR. |
| |
Keywords: | alloantibody animal models: murine B cell biology basic (laboratory) research / science immune regulation immunosuppression / immune modulation kidney transplantation / nephrology |
|
|